ATE355360T1 - Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung - Google Patents

Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Info

Publication number
ATE355360T1
ATE355360T1 AT97945702T AT97945702T ATE355360T1 AT E355360 T1 ATE355360 T1 AT E355360T1 AT 97945702 T AT97945702 T AT 97945702T AT 97945702 T AT97945702 T AT 97945702T AT E355360 T1 ATE355360 T1 AT E355360T1
Authority
AT
Austria
Prior art keywords
strain
lactobacillus acidophilus
lactic ferment
special strain
ferment containing
Prior art date
Application number
AT97945702T
Other languages
English (en)
Inventor
Francois-Marie Luquet
Original Assignee
Bio K & Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio K & Internat Inc filed Critical Bio K & Internat Inc
Application granted granted Critical
Publication of ATE355360T1 publication Critical patent/ATE355360T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/113Acidophilus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/23Lactobacillus acidophilus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus
    • Y10S435/854Lactobacillus acidophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
AT97945702T 1996-11-29 1997-11-28 Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung ATE355360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3215796P 1996-11-29 1996-11-29

Publications (1)

Publication Number Publication Date
ATE355360T1 true ATE355360T1 (de) 2006-03-15

Family

ID=21863414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945702T ATE355360T1 (de) 1996-11-29 1997-11-28 Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Country Status (8)

Country Link
US (1) US6607905B1 (de)
EP (2) EP0951531B1 (de)
AT (1) ATE355360T1 (de)
AU (1) AU5113798A (de)
CA (1) CA2271930C (de)
DE (1) DE69737420T2 (de)
ES (1) ES2283027T3 (de)
WO (1) WO1998023727A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DK1007625T3 (da) 1997-08-21 2010-11-01 New Zealand Dairy Board Immunitetsforstærkede mællkesyrebakterie
US6479051B1 (en) 1998-12-11 2002-11-12 Urex Biotex, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
ES2155782B1 (es) * 1999-05-07 2002-05-16 Danone Sa Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
ES2155783B1 (es) * 1999-05-07 2002-05-16 Danone Sa Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
DE60018919T2 (de) * 1999-05-07 2006-05-18 Compagnie Gervais Danone Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
CA2374937A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
WO2000071139A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
US20030180260A1 (en) * 2000-06-19 2003-09-25 Clancy Robert Llewellyn Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
ES2169675B1 (es) * 2000-07-19 2003-04-16 Danone Sa Producto con propiedades antiinflamatorias para el colon humano.
CA2364249A1 (fr) 2001-11-27 2003-05-27 Unknown-Inconnu Effet de bacteries lactiques sur l'apoptose cellulaire de tumeur
WO2003080813A2 (en) 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
CN1317385C (zh) 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd-II菌株及其在降低血脂方面的应用
CA2448843A1 (fr) * 2003-11-13 2005-05-13 Bio-K Plus International Inc. Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP1880001B1 (de) 2005-05-31 2011-06-08 The Iams Company Feline probiotische lactobacilli
US20110165127A1 (en) * 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
EP2839836B2 (de) * 2006-10-02 2024-06-26 International N&H Denmark ApS Probiotika zur Verwendung bei der Reduzierung des Auftretens und der Dauer von Krankheiten
AU2013201783B2 (en) * 2006-10-02 2015-06-04 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
MX2009006810A (es) * 2006-12-22 2009-11-23 Francois-Marie Luquet Inhibicion del crecimiento de microorganismos por bacterias del acido lactico.
WO2008077251A1 (en) * 2006-12-22 2008-07-03 Bio-K Plus International Inc. Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101250493B (zh) * 2008-04-01 2010-06-02 浙江省农业科学院 固、液二步发酵工艺生产饲用嗜酸乳杆菌的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CL2009001511A1 (es) * 2009-07-02 2009-10-23 Univ De Concepcion 61 02% Formulacion farmaceutica que comprende cepas viables de lactobacillus acidophilus lpv 31 y l. plantarum lpm-01, la cual es util en la prevencion y/o tratamiento de infecciones urinarias y en mejorar la respuesta inmune en pacientes inmunocopromentidos.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR20160022909A (ko) 2013-06-27 2016-03-02 스타벅스 코포레이션 디/비/에이 스타벅스 커피 컴퍼니 음료 및 다른 식품들을 위한 생물보존 방법
AT517321A1 (de) * 2015-06-10 2016-12-15 Trodat Gmbh Stempel
WO2023066973A1 (en) * 2021-10-19 2023-04-27 Kerry Group Services International Limited Probiotic strains for reducing blood cholesterol and/or treating dyslipidemia, and methods for using and producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
DE69219768T2 (de) * 1992-07-06 1997-08-28 Nestle Sa Milchbakterien
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌

Also Published As

Publication number Publication date
ES2283027T3 (es) 2007-10-16
EP2159277A1 (de) 2010-03-03
DE69737420T2 (de) 2007-11-15
EP0951531A1 (de) 1999-10-27
WO1998023727A1 (en) 1998-06-04
CA2271930A1 (en) 1998-06-04
AU5113798A (en) 1998-06-22
US6607905B1 (en) 2003-08-19
CA2271930C (en) 2006-10-17
DE69737420D1 (de) 2007-04-12
EP0951531B1 (de) 2007-02-28

Similar Documents

Publication Publication Date Title
ATE355360T1 (de) Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung
RU93049638A (ru) Молочно-кислая бактерия
DE69224814T2 (de) Den darm kolonisierende laktobacillen
DE69535290D1 (de) Herstellung von durch streptococcus thermophilus fermentierten produkten mit hohem gehalt von galacto-oligosacchariden und beta-galactosidase
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
UA42092C2 (uk) Штам молочнокислих бактерій bifidobacterium breve, штам молочнокислих бактерій bifidobacterium infantis, штам молочнокислих бактерій bifidobacterium longum для покращення кишкової флори, спосіб покращення кишкової флори
NZ502610A (en) Use of lactobacillus for reduction of the fibrinogen level in blood
FR12C0065I1 (de)
HUT39480A (en) Process for preparing antibiotic complex a 40926 and pure components thereof i.e. factors pa, pb, a, b and b down o
BR9609041A (pt) "terapia de substituição para cáries dentais".
DE69030326D1 (de) Zubereitung mit ligninabbauender aktivität, verfahren zu deren herstellung und anwendungen dafür
ATE299177T1 (de) Milchsäurebakterien und ihre anwendung zur herstellung von hypercholesterolemische aktive produkte
EP0486024A3 (en) Lactobacillus sp.b001 and method of producing mannitol, acetic acid and lactic acid
EP0486067A3 (en) Peroxidase gene of microbial origin
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
EP0304897A3 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
AU3846595A (en) Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production
RU92015133A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза
SE9201006D0 (sv) Delignifying preparation exhibiting alpha-l-arabino -furanosidase activity, production and application thereof
DE69225039D1 (de) Mikroorganismen und Verfahren zur Herstellung von 3-Alpha, 7-Alpha-Dihydroxy-12-Keto-Cholansäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951531

Country of ref document: EP

REN Ceased due to non-payment of the annual fee